Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · Real-Time Price · USD
3.660
+0.070 (1.95%)
May 12, 2025, 4:00 PM - Market closed
Qualigen Therapeutics Market Cap
Qualigen Therapeutics has a market cap or net worth of $2.69 million as of May 12, 2025. Its market cap has increased by 41.48% in one year.
Market Cap
2.69M
Enterprise Value
3.84M
1-Year Change
41.48%
Ranking
Category
Stock Price
$3.66
Market Cap Chart
Since June 24, 2015, Qualigen Therapeutics's market cap has decreased from $38.40M to $2.69M, a decrease of -93.00%. That is a compound annual growth rate of -23.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 2.60M | -16.13% |
| Dec 31, 2024 | 3.10M | 10.71% |
| Dec 29, 2023 | 2.80M | -48.15% |
| Dec 30, 2022 | 5.40M | -82.69% |
| Dec 31, 2021 | 31.20M | -55.04% |
| Dec 31, 2020 | 69.40M | 3,982.35% |
| Dec 31, 2019 | 1.70M | -50.00% |
| Dec 31, 2018 | 3.40M | -79.14% |
| Dec 29, 2017 | 16.30M | -43.99% |
| Dec 30, 2016 | 29.10M | 120.45% |
| Dec 31, 2015 | 13.20M | -65.63% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |